DUOPHARMA BIOTECH BERHAD financial statements, including revenue, expenses, profit, and loss

The total revenue of DPHARMA for the last quarter is 167.50 M MYR, and it's 1.02% lower compared to the previous quarter. The net income of Q4 23 is 8.50 M MYR.